Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 43076-61-5
2. 1-(4-(tert-butyl)phenyl)-4-chlorobutan-1-one
3. 1-(4-tert-butylphenyl)-4-chlorobutan-1-one
4. 4'-tertbutyl-4-chlorobutyrophenone
5. 1-(4-tert-butylphenyl)-4-chloro-1-butanone
6. Einecs 256-077-8
7. Butyrophenone Derivative
8. Dsstox_cid_31534
9. Dsstox_rid_97419
10. Dsstox_gsid_57745
11. Schembl2240591
12. 4-chloro-1-[4-(1,1-dimethylethyl)phenyl]- 1-butanone
13. Chembl3185627
14. Dtxsid1057745
15. P-t-butyl-gamma-chlorobutyrophenone
16. Zinc2162166
17. Tox21_113820
18. 4-chloro-4'-tert-butylbutyrophenone
19. Mfcd00018996
20. 4' -tert-butyl-4-chlorobutyrophenone
21. 4-tert-butyl-gamma-chlorobutyrophenone
22. 4\'-tert-butyl-4-chlorobutyrophenone
23. Akos009159383
24. Cs-w009484
25. 4'-tert-butyl-gamma-chlorobutyrophenone
26. Ncgc00253699-01
27. Ac-15785
28. Bs-16808
29. 4'-tert-butyl-4-chlorobutyrophenone, 98%
30. Cas-43076-61-5
31. Db-051023
32. B3144
33. Ft-0619486
34. D88988
35. 1-(4-tert-butyl-phenyl)-4-chloro-butan-1-one
36. 4-chloro-1(1,1-dimethylethyl)phenyl-1-butanone
37. Sr-01000944766
38. Sr-01000944766-1
39. W-110982
40. 4 -chloro-1-[4-(1,1-dimethylethyl)phenyl]-1-butanone
41. F0001-1187
Molecular Weight | 238.75 g/mol |
---|---|
Molecular Formula | C14H19ClO |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 5 |
Exact Mass | 238.1124429 g/mol |
Monoisotopic Mass | 238.1124429 g/mol |
Topological Polar Surface Area | 17.1 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 221 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
84
PharmaCompass offers a list of 4A-Tert-Butyl-4-Chlorobutyrophenone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 4A-Tert-Butyl-4-Chlorobutyrophenone manufacturer or 4A-Tert-Butyl-4-Chlorobutyrophenone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 4A-Tert-Butyl-4-Chlorobutyrophenone manufacturer or 4A-Tert-Butyl-4-Chlorobutyrophenone supplier.
PharmaCompass also assists you with knowing the 4A-Tert-Butyl-4-Chlorobutyrophenone API Price utilized in the formulation of products. 4A-Tert-Butyl-4-Chlorobutyrophenone API Price is not always fixed or binding as the 4A-Tert-Butyl-4-Chlorobutyrophenone Price is obtained through a variety of data sources. The 4A-Tert-Butyl-4-Chlorobutyrophenone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS-43076-61-5 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-43076-61-5, including repackagers and relabelers. The FDA regulates CAS-43076-61-5 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-43076-61-5 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CAS-43076-61-5 supplier is an individual or a company that provides CAS-43076-61-5 active pharmaceutical ingredient (API) or CAS-43076-61-5 finished formulations upon request. The CAS-43076-61-5 suppliers may include CAS-43076-61-5 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-43076-61-5 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CAS-43076-61-5 DMF (Drug Master File) is a document detailing the whole manufacturing process of CAS-43076-61-5 active pharmaceutical ingredient (API) in detail. Different forms of CAS-43076-61-5 DMFs exist exist since differing nations have different regulations, such as CAS-43076-61-5 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CAS-43076-61-5 DMF submitted to regulatory agencies in the US is known as a USDMF. CAS-43076-61-5 USDMF includes data on CAS-43076-61-5's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CAS-43076-61-5 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CAS-43076-61-5 suppliers with USDMF on PharmaCompass.
CAS-43076-61-5 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-43076-61-5 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-43076-61-5 GMP manufacturer or CAS-43076-61-5 GMP API supplier for your needs.
A CAS-43076-61-5 CoA (Certificate of Analysis) is a formal document that attests to CAS-43076-61-5's compliance with CAS-43076-61-5 specifications and serves as a tool for batch-level quality control.
CAS-43076-61-5 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-43076-61-5 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-43076-61-5 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-43076-61-5 EP), CAS-43076-61-5 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-43076-61-5 USP).